199 related articles for article (PubMed ID: 34440927)
1. Proteomic Analysis of Niemann-Pick Type C Hepatocytes Reveals Potential Therapeutic Targets for Liver Damage.
Balboa E; Marín T; Oyarzún JE; Contreras PS; Hardt R; van den Bosch T; Alvarez AR; Rebolledo-Jaramillo B; Klein AD; Winter D; Zanlungo S
Cells; 2021 Aug; 10(8):. PubMed ID: 34440927
[TBL] [Abstract][Full Text] [Related]
2. Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model.
Pergande MR; Cougnoux A; Rathnayake RAC; Porter FD; Cologna SM
Molecules; 2019 Mar; 24(5):. PubMed ID: 30870990
[TBL] [Abstract][Full Text] [Related]
3. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
4. Global Proteomics for Identifying the Alteration Pathway of Niemann-Pick Disease Type C Using Hepatic Cell Models.
Miyoshi K; Hishinuma E; Matsukawa N; Shirasago Y; Watanabe M; Sato T; Sato Y; Kumondai M; Kikuchi M; Koshiba S; Fukasawa M; Maekawa M; Mano N
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958627
[TBL] [Abstract][Full Text] [Related]
5. Standard-flow LC and thermal focusing ESI elucidates altered liver proteins in late stage Niemann-Pick, type C1 disease.
Pergande MR; Zarate E; Haney-Ball C; Davidson CD; Scesa G; Givogri MI; Bongarzone ER; Cologna SM
Bioanalysis; 2019 Jun; 11(11):1067-1083. PubMed ID: 31251104
[No Abstract] [Full Text] [Related]
6. GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice.
van der Lienden MJC; Aten J; Marques ARA; Waas ISE; Larsen PWB; Claessen N; van der Wel NN; Ottenhoff R; van Eijk M; Aerts JMFG
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802460
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.
Subramanian K; Rauniyar N; Lavalleé-Adam M; Yates JR; Balch WE
Mol Cell Proteomics; 2017 Nov; 16(11):1938-1957. PubMed ID: 28860124
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Primary and Secondary Cholesterol Deposition and Damage in Niemann-Pick Disease.
Bosch M; Fajardo A; Alcalá-Vida R; Fernández-Vidal A; Tebar F; Enrich C; Cardellach F; Pérez-Navarro E; Pol A
Am J Pathol; 2016 Mar; 186(3):517-23. PubMed ID: 26784526
[TBL] [Abstract][Full Text] [Related]
9. Complement Component C3 Participates in Early Stages of Niemann-Pick C Mouse Liver Damage.
Klein AD; González de la Vega J; Zanlungo S
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244854
[TBL] [Abstract][Full Text] [Related]
10. Genistein Activates Transcription Factor EB and Corrects Niemann-Pick C Phenotype.
Argüello G; Balboa E; Tapia PJ; Castro J; Yañez MJ; Mattar P; Pulgar R; Zanlungo S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921734
[TBL] [Abstract][Full Text] [Related]
11. Lipidomic Analysis Reveals Altered Fatty Acid Metabolism in the Liver of the Symptomatic Niemann-Pick, Type C1 Mouse Model.
Pergande MR; Serna-Perez F; Mohsin SB; Hanek J; Cologna SM
Proteomics; 2019 Sep; 19(18):e1800285. PubMed ID: 31394590
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.
Cologna SM; Jiang XS; Backlund PS; Cluzeau CV; Dail MK; Yanjanin NM; Siebel S; Toth CL; Jun HS; Wassif CA; Yergey AL; Porter FD
PLoS One; 2012; 7(10):e47845. PubMed ID: 23144710
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.
Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR
Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal vitamin E accumulation in Niemann-Pick type C disease.
Yévenes LF; Klein A; Castro JF; Marín T; Leal N; Leighton F; Alvarez AR; Zanlungo S
Biochim Biophys Acta; 2012 Feb; 1822(2):150-60. PubMed ID: 22120593
[TBL] [Abstract][Full Text] [Related]
15. Lipid homeostasis and lipoprotein secretion in Niemann-Pick C1-deficient hepatocytes.
Kulinski A; Vance JE
J Biol Chem; 2007 Jan; 282(3):1627-37. PubMed ID: 17107950
[TBL] [Abstract][Full Text] [Related]
16. Altered vitamin E status in Niemann-Pick type C disease.
Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
[TBL] [Abstract][Full Text] [Related]
17. Alteration of gene expression profile in Niemann-Pick type C mice correlates with tissue damage and oxidative stress.
Vázquez MC; del Pozo T; Robledo FA; Carrasco G; Pavez L; Olivares F; González M; Zanlungo S
PLoS One; 2011; 6(12):e28777. PubMed ID: 22216111
[TBL] [Abstract][Full Text] [Related]
18. Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels.
Uronen RL; Lundmark P; Orho-Melander M; Jauhiainen M; Larsson K; Siegbahn A; Wallentin L; Zethelius B; Melander O; Syvänen AC; Ikonen E
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1614-20. PubMed ID: 20489167
[TBL] [Abstract][Full Text] [Related]
19. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
20. Recovery from liver disease in a Niemann-Pick type C mouse model.
Sayre NL; Rimkunas VM; Graham MJ; Crooke RM; Liscum L
J Lipid Res; 2010 Aug; 51(8):2372-83. PubMed ID: 20418540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
